These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children. Bolster AA; Hilditch TE Br J Radiol; 1995 Nov; 68(815):1263. PubMed ID: 8542240 [No Abstract] [Full Text] [Related]
45. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine. Troncone L; Riccardi R; Montemaggi P; Rufini V; Lasorella A; Mastrangelo R Med Pediatr Oncol; 1987; 15(4):220-3. PubMed ID: 3657712 [TBL] [Abstract][Full Text] [Related]
46. Results of [131I]metaiodobenzylguanidine therapy administered to two patients with medullary carcinoma of the thyroid. Schvartz C; Delisle MJ J Nucl Biol Med (1991); 1991; 35(4):332-3. PubMed ID: 1823850 [TBL] [Abstract][Full Text] [Related]
47. Malignant retroperitoneal paraganglioma: case report and review of the literature. Buonuomo V; Ruggiero A; Rando G; D'Urzo C; Manzoni C; Pintus C Pediatr Hematol Oncol; 2004 Dec; 21(8):731-8. PubMed ID: 15739629 [TBL] [Abstract][Full Text] [Related]
48. Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans. Hattner RS; Pounds TR; Matthay KK Clin Nucl Med; 1994 Nov; 19(11):985-8. PubMed ID: 7842595 [TBL] [Abstract][Full Text] [Related]
49. [131I-MIBG therapy in the treatment of pheochromocytoma in children--own experiences]. Hasse-Lazar K; Krajewska J; Paliczka-Cieślik E; Jurecka-Lubieniecka B; Michalik B; Handkiewicz-Junak D; Roskosz J; Jarzab B Endokrynol Pol; 2008; 59(3):235-40. PubMed ID: 18615399 [TBL] [Abstract][Full Text] [Related]
50. Meta-[I-131]iodobenzylguanidine uptake in a nonsecreting paraganglioma. Smit AJ; van Essen LH; Hollema H; Muskiet FA; Piers DA J Nucl Med; 1984 Sep; 25(9):984-6. PubMed ID: 6470814 [TBL] [Abstract][Full Text] [Related]
51. Functional imaging as an aid to decision-making in metastatic paraganglioma. Bomanji JB; Hyder SW; Gaze MN; Gacinovic S; Costa DC; Coulter C; Ell PJ Br J Radiol; 2001 Mar; 74(879):266-9. PubMed ID: 11338105 [TBL] [Abstract][Full Text] [Related]
52. [Scintigraphy with iodine-131 metaiodobenzylguanidine in the study of paraganglioma. Comparison between benign and malignant tumors]. Maurea S; Cuocolo A; Reynolds J; Keiser H; Neumann R; Salvatore M Radiol Med; 1994 May; 87(5):688-93. PubMed ID: 8008902 [TBL] [Abstract][Full Text] [Related]
54. Paraganglioma of urinary bladder, visualization with 131I-MIBG scintigraphy. Sakashita S; Tanda K; Togashi M; Maru A; Koyanagi T; Tsukamoto E; Itoh K Urol Int; 1987; 42(3):237-40. PubMed ID: 3617264 [TBL] [Abstract][Full Text] [Related]
55. The role of I-131-MIBG in the diagnosis and therapy of carcinoids. Hoefnagel CA; den Hartog Jager FC; Taal BG; Abeling NG; Engelsman EE Eur J Nucl Med; 1987; 13(4):187-91. PubMed ID: 2441993 [TBL] [Abstract][Full Text] [Related]
56. (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. van Hulsteijn LT; Niemeijer ND; Dekkers OM; Corssmit EP Clin Endocrinol (Oxf); 2014 Apr; 80(4):487-501. PubMed ID: 24118038 [TBL] [Abstract][Full Text] [Related]
57. Session on: has [131I]metaiodobenzylguanidine a role in the treatment of medullary thyroid cancer and carcinoid tumors? Chairman's report. Bestagno M J Nucl Biol Med (1991); 1991; 35(4):355-6. PubMed ID: 1823857 [No Abstract] [Full Text] [Related]
58. [Treatment of malignant pheochromocytoma by 131-I-metaiodobenzylguanidine]. Charbonnel B; Chatal JF; Brendel AJ; Lanehche B; Lumbroso J; Marchandise X; Mornex R; Schlumberger M; Wemeau JL Ann Endocrinol (Paris); 1988; 49(4-5):344-7. PubMed ID: 3202602 [TBL] [Abstract][Full Text] [Related]